Get the Stockscreener App
88.44
1.34%
-1.20
Lemaitre Vascular Inc stock is traded at $88.44, with a volume of 109.10K.
It is down -1.34% in the last 24 hours and up +1.21% over the past month.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
See More
Previous Close:
$89.64
Open:
$89.74
24h Volume:
109.10K
Relative Volume:
0.66
Market Cap:
$2.00B
Revenue:
$213.03M
Net Income/Loss:
$41.32M
P/E Ratio:
48.33
EPS:
1.83
Net Cash Flow:
$33.49M
1W Performance:
+1.87%
1M Performance:
+1.21%
6M Performance:
+6.55%
1Y Performance:
-12.88%
1-Day Range:
$87.73
$89.74
1-Week Range:
$85.27
$92.25
52-Week Range:
$71.42
$109.58
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Name
Lemaitre Vascular Inc
Sector
Industry
Phone
781-221-2266
Address
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
88.44 | 2.03B | 213.03M | 41.32M | 33.49M | 1.83 |
|
ISRG
Intuitive Surgical Inc
|
549.51 | 200.47B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.04 | 55.33B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
77.65 | 38.61B | 10.19B | 1.05B | 1.39B | 2.1065 |
|
RMD
Resmed Inc
|
244.46 | 36.80B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
261.36 | 19.18B | 2.96B | 487.70M | 344.00M | 6.6758 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-06-25 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Feb-28-25 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Feb-28-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-13-25 | Initiated | Wells Fargo | Equal Weight |
| Oct-15-24 | Initiated | Cantor Fitzgerald | Neutral |
| Aug-02-24 | Resumed | Lake Street | Buy |
| May-31-24 | Resumed | ROTH MKM | Buy |
| Apr-26-24 | Upgrade | Stifel | Hold → Buy |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Sector Weight |
| Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-06-23 | Initiated | Oppenheimer | Outperform |
| Aug-03-23 | Downgrade | Jefferies | Buy → Hold |
| May-03-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-28-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-16-21 | Initiated | Jefferies | Buy |
| Feb-12-21 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Mar-16-20 | Upgrade | Sidoti | Neutral → Buy |
| Oct-24-19 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Oct-24-19 | Upgrade | Lake Street | Hold → Buy |
| Oct-14-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Jul-25-19 | Reiterated | Barrington Research | Outperform |
| Jul-25-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
| Oct-08-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-08-18 | Upgrade | ROTH Capital | Neutral → Buy |
| Jun-08-18 | Resumed | ROTH Capital | Buy |
| Apr-26-18 | Downgrade | Stifel | Buy → Hold |
| Apr-26-18 | Upgrade | The Benchmark Company | Hold → Buy |
| Oct-27-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| Oct-27-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-10-17 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jul-10-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Mar-21-17 | Initiated | First Analysis Sec | Overweight |
| Feb-22-17 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-22-16 | Downgrade | Sidoti | Buy → Neutral |
| Jul-28-16 | Reiterated | Barrington Research | Outperform |
| Feb-25-16 | Reiterated | Barrington Research | Outperform |
View All
Lemaitre Vascular Inc Stock (LMAT) Latest News
Using Bollinger Bands to evaluate LeMaitre Vascular Inc.Trade Exit Summary & Risk Controlled Stock Alerts - newser.com
What hedge fund moves indicate for LeMaitre Vascular Inc. (LHU) stockJuly 2025 Institutional & High Accuracy Buy Signal Tips - newser.com
Is LeMaitre Vascular Inc. stock a safe buy before earningsWeekly Stock Summary & Daily Volume Surge Signals - newser.com
Will LeMaitre Vascular Inc. stock remain a Wall Street favoriteDip Buying & Stock Portfolio Risk Management - newser.com
Will LeMaitre Vascular Inc. (LHU) stock announce special dividend2025 Price Targets & Safe Entry Trade Signal Reports - newser.com
Will LeMaitre Vascular Inc. (LHU) stock enhance shareholder value2025 Top Gainers & Stepwise Trade Signal Implementation - newser.com
Will LeMaitre Vascular Inc. stock attract more institutional investors2025 Top Gainers & Step-by-Step Trade Execution Guides - newser.com
Why LeMaitre Vascular Inc. (LHU) stock signals breakout potentialPortfolio Performance Report & Reliable Intraday Trade Plans - newser.com
Will LeMaitre Vascular Inc. stock benefit from green energy trendsQuarterly Profit Summary & Consistent Growth Equity Picks - newser.com
Will earnings trigger a reversal in LeMaitre Vascular Inc.July 2025 Snapshot & Fast Moving Stock Watchlists - newser.com
LeMaitre to Participate in Upcoming Investor Conferences - The Manila Times
LeMaitre (Nasdaq: LMAT) to join Jefferies, Wolfe and Piper Sandler investor conferences - Stock Titan
Will LeMaitre Vascular Inc. (LHU) stock keep high P E multiplesQuarterly Trade Summary & Risk Managed Investment Signals - newser.com
LeMaitre Vascular Experiences Revision in Its Stock Evaluation Amid Competitive Market Dynamics - Markets Mojo
What technical patterns form on LeMaitre Vascular Inc. (LHU) stock chartsTreasury Yields & Real-Time Volume Triggers - newser.com
LeMaitre Vascular stock holds Neutral rating at Cantor Fitzgerald after Q3 results By Investing.com - Investing.com Australia
Is LeMaitre Vascular Inc. stock ready for a breakout2025 Price Momentum & Fast Exit Strategy with Risk Control - newser.com
Applying Elliott Wave Theory to LeMaitre Vascular Inc.2025 Market Trends & Accurate Buy Signal Alerts - newser.com
LeMaitre Vascular stock holds Neutral rating at Cantor Fitzgerald after Q3 results - Investing.com UK
Roth Capital Has Bullish Forecast for LMAT FY2025 Earnings - MarketBeat
Will LeMaitre Vascular Inc. (LHU) stock beat Nasdaq index returnsStop Loss & Weekly Top Gainers Trade List - newser.com
What catalysts could drive LeMaitre Vascular Inc. stock higherPortfolio Value Summary & Verified Swing Trading Watchlist - newser.com
LeMaitre targets 40% Q4 operating income growth and 29% margin as Artegraft expansion accelerates - MSN
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q3 2025 Earnings Call Transcript - Insider Monkey
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zymeworks (ZYME), MBX Biosciences, Inc. (MBX) and Lemaitre Vascular (LMAT) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM), Lemaitre Vascular (LMAT) and Shattuck Labs (STTK) - The Globe and Mail
LeMaitre Vascular (NASDAQ:LMAT) Price Target Lowered to $93.00 at Wells Fargo & Company - MarketBeat
LeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Yahoo Finance
Equities Analysts Offer Predictions for LMAT Q3 Earnings - MarketBeat
LeMaitre Vascular (LMAT) Q3 Earnings Surpass Estimates - sharewise.com
Decoding LeMaitre Vascular Inc (LMAT): A Strategic SWOT Insight - GuruFocus
LeMaitre Vascular (NASDAQ:LMAT) Issues Earnings Results - MarketBeat
LeMaitre Vascular’s Earnings Call: Growth Amid Challenges - TipRanks
Lemaitre Vascular Inc Stock (LMAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.23%
0.58%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):